- Presentation will highlight the technology of pH-sensitive micelles for tumor-agnostic intraoperative detection of residual...
Read More
Funding will support pre-clinical and clinical development through Phase 1 trial of ONM500, an immunoadjuvant...
Read More
Proceeds will be used to support new and ongoing cancer imaging clinical trials and to...
Read More
ONM-100 was able to detect occult disease which was otherwise missed by standard surgery and...
Read More
FDA says proposed Phase 2 clinical trial may proceed SOUTHLAKE, TX. – January 4, 2019...
Read More
Results Selected for Poster presentation at San Antonio Breast Cancer Symposium SOUTHLAKE, TX. –December 5,...
Read More
The study, being conducted at TRACER Center of Expertise, University Medical Center in Groningen, The...
Read More
SOUTHLAKE, TX. – May 17, 2018 – OncoNano Medicine, Inc. today announced the closing of...
Read More